| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA5216985 | B | Inhibition of norepinephrine transporter (unknown origin) assessed as inhibition of norepinephrine reuptake | Homo sapiens | 5 | single protein format | Scientific Literature | ||
| 2. | ALA5216986 | B | Inhibition of dopamine transporter (unknown origin) assessed as inhibition of dopamine reuptake | Homo sapiens | 5 | single protein format | Scientific Literature | ||
| 3. | ALA5216987 | B | Binding affinity to recombinant CYP2B6 (unknown origin) assessed as spectral dissociation constant-1 | Homo sapiens | 5 | single protein format | Scientific Literature | ||
| 4. | ALA5216988 | B | Binding affinity to recombinant CYP2B6 (unknown origin) assessed as spectral dissociation constant-2 | Homo sapiens | 5 | single protein format | Scientific Literature | ||
| 5. | ALA5216990 | A | Drug metabolism assessed as CYP2B6 (unknown origin)-mediated d9-BuOH metabolite formation by measuring km | Homo sapiens | 2 | single protein format | Scientific Literature | ||
| 6. | ALA5216994 | A | Drug metabolism assessed as CYP2B6 (unknown origin)-mediated d9-BuOH metabolite formation by measuring Kcat | Homo sapiens | 2 | single protein format | Scientific Literature | ||
| 7. | ALA5216997 | A | Drug metabolism assessed as CYP2B6 (unknown origin)-mediated d9-BuOH metabolite formation by measuring intrinsic clearance | Homo sapiens | 2 | single protein format | Scientific Literature | ||
| 8. | ALA5216998 | A | Inhibition of CYP2B6-mediated metabolism in human liver microsomes assessed as fold reduction in R,R-hydroxybupropion formation | Homo sapiens | 2 | microsome format | Scientific Literature | ||
| 9. | ALA5217002 | A | Inhibition of CYP2B6-mediated metabolism in human hepatocytes assessed as reduction in oxidation product formation | Homo sapiens | 2 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!